MetLife Whole and Term Life & Endowments — Benefit payments decreased by 3.6% to -$256.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from -$244.00M to -$256.00M. Over 4 years (FY 2021 to FY 2025), Whole and Term Life & Endowments — Benefit payments shows an upward trend with a -14.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher payments relative to premiums may indicate higher mortality or lapse rates than originally priced.
This represents the actual cash outflows made to policyholders or beneficiaries for claims, maturities, or surrenders wi...
A standard cash flow metric for all life insurance companies.
met_segment_whole_and_term_life_endowments_benefit_payments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$448.50M | -$448.50M | -$448.50M | -$419.00M | -$368.00M | -$301.00M | -$318.00M | -$340.00M | -$284.00M | -$271.00M | -$279.00M | -$263.00M | -$221.00M | -$242.00M | -$232.00M | -$244.00M | -$238.00M | -$241.00M | -$247.00M | -$256.00M |
| QoQ Change | — | +0.0% | +0.0% | +6.6% | +12.2% | +18.2% | -5.6% | -6.9% | +16.5% | +4.6% | -3.0% | +5.7% | +16.0% | -9.5% | +4.1% | -5.2% | +2.5% | -1.3% | -2.5% | -3.6% |
| YoY Change | — | — | — | — | +17.9% | +32.9% | +29.1% | +18.9% | +22.8% | +10.0% | +12.3% | +22.6% | +22.2% | +10.7% | +16.8% | +7.2% | -7.7% | +0.4% | -6.5% | -4.9% |